- 17.10.2020: Recent publication in "Cancer Gene Therapy"! A new study from CBU identified a critical role for the understudied , atypical MAPK ERK3 in controlling KRAS-mediated Non small cell lung carcinomas. KRAS is one of the most frequently mutated oncogenes and mechanisms driving tumourigenesis mediated by this oncogene have been intensively studied. Our new work demonstrated that the kinase activity of ERK3 is required for KRAS-mediated NSCLCs thus prompting development of ERK3 specific inhibitors. To read the full story click here
- 25.06.20: Recent publication in "Nature Communications" describes the identification of new druggable targets and of a novel TFG-RET gene fusion in papillary thyroid carcinomas!
- 17.01.20: Memorandum of Understanding signed with IMCB of the Agency for Science (A*STAR) of Singapur: Closer Cooperation in research and in the training of young scientists is initiated.
- 05.04.19: We are Leica Reference Center. For the German press release please click here
- 11.09.2018: Interview with Krishnaraj Rajalingam about his career from the Emmy-Noether-program of the DFG to the Heisenberg professorship
- 20.08.2018: Publication in EMBO Journal describes a new therapeutic approach against multiple sclerosis
- 04.05.2018: Else Kröner-Fresenius-Foundation supports research project of Prof. Dr. Rajalingam to explore new therapeutic approaches against lung cancer
- 23.04.2018: Deutsche Krebshilfe is now funding a innovative science project to find new therapeutic approaches against papillary thyroid carcinoma
- 30.05.2016 Gutenberg Research College welcomes new member and bestows the Gutenberg Research Award 2016
12.05.2016 Vishva Dixit receives the Gutenberg Research Award 2016 for his work on apoptotic signaling and visits Prof. Krishnaraj Rajalingam´s Molecular Signaling Unit
- 05.05.2015: Gutenberg Research College welcomes new members and the Gutenberg Research Award 2015 is granted
08.12.2014: New Molecular Signaling Unit of the Research Center for Immunotherapy (FZI) initiated by the Heisenberg professor Krishnaraj Rajalingam
30.10.2014: GFK fellow Krishnaraj Rajalingam joins the team of the Research Center for Immunotherapy at Johannes Gutenberg University Mainz
21.07.2014: Molecular biologist Krishnaraj Rajalingam receives Heisenberg professorship at University Medical Center Mainz